Genesis is an AI co-pilot for women's health that transforms complex biological data into clear, actionable insights for both patients and their healthcare providers. The platform is currently in early access with a waitlist of over 2,000 individuals, signaling strong initial demand. Genesis serves as a decision-support layer that aims to improve communication and care outcomes in women's health settings.
- Artificial Intelligence
- Digital Health
- Healthcare Technology
- Software Only
Funding
Funding not disclosed
Founders
Product
Problem
Women's health conditions are often driven by complex biological data that is difficult for patients to interpret and for providers to synthesize into timely, personalized care plans. This complexity can lead to delayed diagnoses, miscommunication between patients and clinicians, and missed opportunities for proactive health management.
Solution
Genesis provides an AI-powered co-pilot platform designed to bridge the gap between raw biological data and clinical action. The platform analyzes patient data to generate clear, actionable insights that women can understand and share directly with their healthcare providers, enhancing shared decision-making. For clinicians, Genesis offers a workflow-integrated tool that surfaces key health signals and recommended next steps, reducing time spent on data interpretation and enabling more personalized treatment strategies.
Target Audience
The primary audience includes women seeking a better understanding of their biological health data, alongside healthcare providers and clinics specializing in women's health who want to streamline data interpretation and improve patient engagement.
Features
- AI-driven data analysis engine that converts complex biological markers into plain-language, patient-friendly insights
- Provider-facing dashboard designed to highlight actionable health trends and support clinical decision-making
- Shared insight framework that facilitates better patient-provider communication and collaborative care planning
- Early access program with a community of 2,000+ waitlisted users, indicating product-market fit validation for a women's health audience